<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: bioethicists</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Ethicists provide framework supporting new recommendations on reporting incidental findings in gene sequencing</title>
   	 <description>In a paper published in Science Express, a group of experts led by bioethicists in the Center for Medical Ethics and Health Policy at Baylor College of Medicine provide a framework for the new American College of Medical Genetics and Genomics (ACMG) recommendations on reporting incidental findings in clinical exome and genome sequencing.</description>
     <link>http://medicalxpress.com/news/2013-05-ethicists-framework-incidental-gene-sequencing.html</link>
	 <category>Genetics</category>
	 <pubDate>Thu, 16 May 2013 14:00:01 EST</pubDate>
	 <guid isPermaLink="false">news287931187</guid>
	 
</item>
<item>
     <title>Experts aim to redefine healthcare and research ethics</title>
   	 <description>In what they acknowledge as a seismic shift in the ethical foundation of medical research, practice and policy, a prominent group of interdisciplinary healthcare experts, led by bioethicists at Johns Hopkins, rejects an ethical paradigm that has guided the American system since the 1970s and calls for morally obligatory participation in a &quot;learning healthcare system&quot; more in step with the digital age. The group has authored a pair of articles outlining their arguments and proposal for a new ethical framework, which appear in a special report from The Hastings Center Report, along with seven commentaries from other experts responding to their ideas.</description>
     <link>http://medicalxpress.com/news/2013-01-experts-aim-redefine-healthcare-ethics.html</link>
	 <category>Health</category>
	 <pubDate>Fri, 11 Jan 2013 13:15:32 EST</pubDate>
	 <guid isPermaLink="false">news277132280</guid>
	 
</item>
<item>
     <title>'Queer Bioethics': The birth of a new academic discipline</title>
   	 <description>It's not every day that a new academic discipline is born. But that's exactly what happened in 2010, when the Project on Bioethics, Sexuality and Gender Identity — or &quot;Queer Bioethics,&quot; for short—came to life at the University of Pennsylvania.</description>
     <link>http://medicalxpress.com/news/2012-09-queer-bioethics-birth-academic-discipline.html</link>
	 <category>Other</category>
	 <pubDate>Fri, 21 Sep 2012 07:21:52 EST</pubDate>
	 <guid isPermaLink="false">news267430902</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/queerbioethi.jpg" width="90" height="90" />
</item>
<item>
     <title>Bioethicists urge less regulatory burden for low-risk comparative effectiveness research</title>
   	 <description>In an opinion article published in this week's theme edition of the Journal of the American Medical Association focusing on comparative effectiveness research, a team of Johns Hopkins University bioethicists argues forcefully for streamlining federal restrictions on at least some low-risk clinical comparative effectiveness research, instead of easing them &amp;#150; as is now proposed &amp;#150; solely for low-risk social and behavior research involving surveys, interviews and focus groups.</description>
     <link>http://medicalxpress.com/news/2012-04-bioethicists-urge-regulatory-burden-low-risk.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 17 Apr 2012 16:00:08 EST</pubDate>
	 <guid isPermaLink="false">news253884280</guid>
	 
</item>
<item>
     <title>Study gauges emotional toll of direct-to-consumer genetic testing</title>
   	 <description>Among the latest health care trends seeking to advance &quot;individualized medicine&quot; are private companies marketing genetic testing directly to patients. The mail-in kits, with price tags as high as $2,500, use a saliva specimen to identify small variations in the human genome (called &quot;single nucleotide polymorphisms&quot; or &quot;SNPs&quot;) associated with heightened risk for diseases such as diabetes and prostate cancer. The U.S. Food and Drug Administration  has raised concerns about whether the tests are clinically beneficial and has advocated they be conducted under medical supervision, but few studies to date have investigated the emotional effects that direct-to-consumer genetic screens have on patients.</description>
     <link>http://medicalxpress.com/news/2011-10-gauges-emotional-toll-direct-to-consumer-genetic.html</link>
	 <category>Health</category>
	 <pubDate>Mon, 03 Oct 2011 15:57:12 EST</pubDate>
	 <guid isPermaLink="false">news236876219</guid>
	 
</item>


</channel>
</rss>
